Cypherpunk Technologies IncCYPH
Price$2.92

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $0TTM through 31 Mar 2026
Net Income -$77.2MTTM through 31 Mar 2026
Free Cash Flow -$3.4MTTM through 31 Mar 2026

Margins

Current

Returns

-91.5%ROE
-88.4%ROA

Balance Sheet Health

Debt / Equity0.00x
Current Ratio2.49x
Net Debt-$6.7Mnet cash position
Cash & Equivalents$6.7M

Quality Metrics

Earnings-Beat Rate50.0%

Dividend

No dividend

Segment Performance

SegmentRevenueYoYOutlook
Privacy Technology and Digital Asset Treasury$0
View details

Focused on accumulating Zcash (ZEC) to reach at least 5% of the circulating supply and investing in privacy-preserving technologies.

Biotechnology (Leap Therapeutics)$0
View details

Continuing clinical development of biomarker-targeted antibody therapies, including sirexatamab and FL-501.

All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.